Trial Profile
Clinical Trials Insight: 700032517
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2008
Price :
$35
*
At a glance
- Drugs Wetimicin (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Aida Pharmaceuticals
- 14 Apr 2008 New trial record.
- 09 Apr 2008 The trial is expected to begin in 2008.